2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Renal Pelvis Cancer: new trials by email Literature Review of Renal Pelvis Cancer trials Research Report on Renal Pelvis Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function Vinflunine, Gemcitabine, Carboplatin - Urothelial Carcinoma, Bladder Cancer | Phase 2 | Completed | Dr Anders Ullén | 62 | 2014-04-01 | 2019-10-08 |
| A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer AZD4877 - Bladder Cancer, Transitional Cell Bladder Cancer | Phase 2 | Completed | AstraZeneca | 54 | 2008-05-01 | 2011-01-12 |
Ureteral Neoplasms (2) · Urethral Neoplasms (2) · Urinary Bladder Neoplasms (2) · Carcinoma, Transitional Cell (1) · Recurrence (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Ureteral Diseases (2) · Urethral Diseases (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Urologic Diseases (2) · Urologic Neoplasms (2) · Carcinoma (1) · Disease Attributes (1) · Neoplasms by Histologic Type (1)
Carboplatin (1) · Gemcitabine (1) · N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide (1) · vinflunine (1)
AstraZeneca (1) · Dr Anders Ullén (1)
Canada (1) · Denmark (1) · Germany (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Gary Hudes, MD (1)